Dialysis without heparin: a safety study
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether dialysis can be done safely without using heparin (a blood thinner) in people with end-stage kidney disease. If successful, it could reduce the need for blood-thinning medications and their associated risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have been on dialysis for more than 3 months, with each session lasting at least 4 hours.
- You must not be taking any blood-thinning medications (other than what is given during dialysis).
- You must not have had a bad reaction to heparin in the past or have low platelets from heparin.
- You must not have any active bleeding or be at high risk for bleeding (e.g., recent surgery, stroke, or head injury within the last 7 days).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new way to do hemodialysis to better remove waste products that build up in the blood. It may help improve dialysis treatment for people with kidney failure.
This study compares two dialysis membranes while using a reduced “weaning” plan for the blood thinner heparin during hemodialysis. It aims to see which membrane works better and safely during routine chronic dialysis.
This trial tests three experimental antibodies given to people with end-stage kidney disease who are on hemodialysis. It aims to see if these drugs are safe and how they affect blood clotting in this group.
This study compares two ways to prevent blood from clotting during a type of dialysis called hemodiafiltration. You may get either a standard drug (heparin) or a newer approach using citrate to keep your dialysis filter from clotting.
This study tests whether adding a low dose of a blood thinner called apixaban (also known as Eliquis) to the standard solution used to keep dialysis catheters open will help prevent them from getting blocked. It could improve the reliability of your dialysis treatments and reduce the need for catheter replacements.
This study compares two blood-thinning medications used during continuous dialysis for acute kidney injury: one uses citrate (a chemical that prevents clotting) and the other uses heparin (a standard blood thinner). By looking at how well these treatments work, the study aims to find the safest and most effective way to keep the dialysis filter working.
Hear when a new End Stage Renal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.